Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
US Army
Cipla
Accenture
Julphar
Johnson and Johnson
Boehringer Ingelheim
US Department of Justice
QuintilesIMS

Generated: October 17, 2017

DrugPatentWatch Database Preview

Teva Branded Pharm Company Profile

« Back to Dashboard

What is the competitive landscape for TEVA BRANDED PHARM, and what generic alternatives to TEVA BRANDED PHARM drugs are available?

TEVA BRANDED PHARM has twenty-five approved drugs.

There are forty-six US patents protecting TEVA BRANDED PHARM drugs.

There are five hundred and seventy-nine patent family members on TEVA BRANDED PHARM drugs in thirty-seven countries and twelve supplementary protection certificates in nine countries.

Summary for Applicant: Teva Branded Pharm

International Patents:579
US Patents:46
Tradenames:24
Ingredients:14
NDAs:25
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Branded Pharm
AUSTEDO
deutetrabenazine
TABLET;ORAL208082-001Apr 3, 2017RXYesNo► Subscribe► SubscribeY ► Subscribe
Teva Branded Pharm
PROAIR HFA
albuterol sulfate
AEROSOL, METERED;INHALATION021457-001Oct 29, 2004BXRXYesYes► Subscribe► SubscribeY ► Subscribe
Teva Branded Pharm
VANTRELA ER
hydrocodone bitartrate
TABLET, EXTENDED RELEASE;ORAL207975-005Jan 17, 2017RXYesNo► Subscribe► SubscribeY ► Subscribe
Teva Branded Pharm
PROAIR RESPICLICK
albuterol sulfate
POWDER, METERED;INHALATION205636-001Mar 31, 2015RXYesYes► Subscribe► SubscribeY ► Subscribe
Teva Branded Pharm
QVAR 40
beclomethasone dipropionate
AEROSOL, METERED;INHALATION020911-002Sep 15, 2000RXYesYes► Subscribe► SubscribeY ► Subscribe
Teva Branded Pharm
QUARTETTE
ethinyl estradiol; levonorgestrel
TABLET;ORAL204061-001Mar 28, 2013ABRXYesYes► Subscribe► Subscribe ► Subscribe
Teva Branded Pharm
PROAIR RESPICLICK
albuterol sulfate
POWDER, METERED;INHALATION205636-001Mar 31, 2015RXYesYes► Subscribe► SubscribeY ► Subscribe
Teva Branded Pharm
ZECUITY
sumatriptan succinate
SYSTEM;IONTOPHORESIS202278-001Jan 17, 2013DISCNYesNo► Subscribe► Subscribe ► Subscribe
Teva Branded Pharm
VANTRELA ER
hydrocodone bitartrate
TABLET, EXTENDED RELEASE;ORAL207975-001Jan 17, 2017RXYesNo► Subscribe► SubscribeY ► Subscribe
Teva Branded Pharm
CENESTIN
estrogens, conjugated synthetic a
TABLET;ORAL020992-003Mar 24, 1999DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Teva Branded Pharm

Paragraph IV activity for TEVA BRANDED PHARM drugs

Drugname Dosage Strength Tradename Submissiondate
levonorgestrel; ethinyl estradiol;ethinyl estradiol
Tablets0.15 mg/0.02 mg, 0.15 mg/0.025 mg, 0.15 mg/0.03 mg and 0.01 mg
QUARTETTE
7/10/2013
levonorgestrel;ethinyl estradiol;ethinyl estradiol
Tablets0.1 mg/0.02 mg and 0.01 mg
LOSEASONIQUE
11/16/2009
conjugated estrogen (synthetic a)
Tablets0.3 mg, 0.45 mg and 0.9 mg
CENESTIN
3/19/2009
conjugated estrogen (synthetic a)
Tablets0.625 mg
CENESTIN
3/2/2009
conjugated estrogen (synthetic a)
Tablets1.25 mg
CENESTIN
11/3/2008
levonorgestrel; ethinyl estradiol; ethinyl estradiol
Tablets0.15 mg/0.03 mg/0.01 mg
SEASONIQUE
1/22/2008
levonorgestrel and ethinyl estradiol
Tablets0.15 mg/0.03 mg
SEASONALE
3/29/2004

Premature patent expirations for TEVA BRANDED PHARM

Expiration due to failure to pay maintenance fee

Patent Number Expiration Date
► Subscribe ► Subscribe

Non-Orange Book Patents for Teva Branded Pharm

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,737,674Dose counters for inhalers, inhalers and methods of assembly thereof► Subscribe
7,749,989Estrogenic compounds, methods of using and methods of administering the same► Subscribe
8,680,084Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology► Subscribe
7,101,534Suspension aerosol formulations► Subscribe
7,772,219Methods of hormonal treatment utilizing extended cycle contraceptive regimens► Subscribe
6,250,127 Heat-dissipating aluminum silicon carbide composite manufacturing method► Subscribe
6,655,381 Pre-metered dose magazine for breath-actuated dry powder inhaler► Subscribe
9,108,010Dose counters for inhalers, inhalers and methods of assembly thereof► Subscribe
9,533,111Dose counters for inhalers, inhalers and methods of assembly thereof► Subscribe
8,338,396Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Teva Branded Pharm Drugs

Country Document Number Estimated Expiration
Japan5900932► Subscribe
European Patent Office2296597► Subscribe
Hong Kong1221919► Subscribe
European Patent Office2514462► Subscribe
European Patent Office2073795► Subscribe
Eurasian Patent Organization201590907► Subscribe
Spain2343511► Subscribe
China105903113► Subscribe
Eurasian Patent Organization201100056► Subscribe
Australia2008237614► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Teva Branded Pharm Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1214076/01Switzerland► SubscribePRODUCT NAME: DROSPIRENONE + ETHINYLESTRADIOL; REGISTRATION NUMBER/DATE: SWISSMEDIC 57946 13.06.2008
00221Netherlands► SubscribePRODUCT NAME: DROSPIRENON EN ETHINYLESTRADIOL; REGISTRATION NO/DATE: RVG 23827 20000307
C0001France► SubscribePRODUCT NAME: ETHINYLESTRADIOL BETADEX CLATHRATE; NAT. REGISTRATION NO/DATE: NL 32343 20060710; FIRST REGISTRATION: NL - RVG 31781 20050804
2006 00038Denmark► SubscribePRODUCT NAME: ETHINYLESTRADIOL (SOM BETA-CYCLODEXTRIN-CLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 38687 20060627; FIRST REG. NO/DATE: EU RVG 31781 20050804
2016 00016Denmark► SubscribePRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211
00C/027Belgium► SubscribePRODUCT NAME: ETHINYLESTRADIOLUM / NORETHISTERONI ACETAS; NAT. REGISTRATION NO/DATE: 19 IS 106 F3 20000911; FIRST REGISTRATION: NL RVG 23909 19991124
0814Netherlands► SubscribePRODUCT NAME: LEVONORGESTREL EN ETHINYLESTRADIOL; NATIONAL REGISTRATION NO/DATE: RVG 117453 20151211; FIRST REGISTRATION: SK 17/0017/15-S 20150211
/2015Austria► SubscribePRODUCT NAME: ETHINYLESTRADIOL UND EINE KOMBINATION VON LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 136021 20150224; FIRST REGISTRATION: SK 17/0017/15-S 20150211
2015000093Germany► SubscribePRODUCT NAME: LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 87675.00.00 20150720; FIRST REGISTRATION: SLOWAKEI 17/0017/15-S 20150129
0160011 00192Estonia► SubscribePRODUCT NAME: LEVONORGESTREEL JA ETUENUEUELOESTRADIOOL;REG NO/DATE: EE 894715 11.11.2015
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Baxter
Merck
Healthtrust
US Army
Fuji
Moodys
Chinese Patent Office
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot